Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | |
| Опубликовано: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_eddf79e15e2e43ea817a3dc27e173bb2 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Nina V. Vorobjeva |e author |
| 700 | 1 | 0 | |a Galina F. Sud'ina |e author |
| 700 | 1 | 0 | |a Boris V. Chernyak |e author |
| 245 | 0 | 0 | |a Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 |
| 260 | |b Frontiers Media S.A., |c 2021-01-01T00:00:00Z. | ||
| 500 | |a 1663-9812 | ||
| 500 | |a 10.3389/fphar.2021.609508 | ||
| 546 | |a EN | ||
| 690 | |a pneumonia | ||
| 690 | |a COVID-19 | ||
| 690 | |a neutrophils | ||
| 690 | |a mitochondria | ||
| 690 | |a reactive oxygen species | ||
| 690 | |a NADPH oxidase | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Pharmacology, Vol 12 (2021) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2021.609508/full | |
| 787 | 0 | |n https://doaj.org/toc/1663-9812 | |
| 856 | 4 | 1 | |u https://doaj.org/article/eddf79e15e2e43ea817a3dc27e173bb2 |z Connect to this object online. |